Related Experiment Video
Updated: Jul 7, 2026

Ubiquitin Chain Analysis by Parallel Reaction Monitoring
Published on: June 17, 2020
Control of AMPK-related kinases by USP9X and atypical Lys(29)/Lys(33)-linked polyubiquitin chains
Abdallah K Al-Hakim1, Anna Zagorska, Louise Chapman
1MRC Protein Phosphorylation Unit, MSI/WTB Complex, University of Dundee, Dow Street, Dundee DD1 5EH, Scotland, UK.
Abstract:
AMPK (AMP-activated protein kinase)-related kinases regulate cell polarity as well as proliferation and are activated by the LKB1-tumour suppressor kinase. In the present study we demonstrate that the AMPK-related kinases, NUAK1 (AMPK-related kinase 5) and MARK4 (microtubule-affinity-regulating kinase 4), are polyubiquitinated in vivo and interact with the deubiquitinating enzyme USP9X (ubiquitin specific protease-9). Knockdown of USP9X increased polyubiquitination of NUAK1 and MARK4, whereas overexpression of USP9X inhibited ubiquitination. USP9X, catalysed the removal of polyubiquitin chains from wild-type NUAK1, but not from a non-USP9X-binding mutant. Topological analysis revealed that ubiquitin monomers attached to NUAK1 and MARK4 are linked by Lys(29) and/or Lys(33) rather than the more common Lys(48)/Lys(63). We find that AMPK and other AMPK-related kinases are also polyubiquitinated in cells. We identified non-USP9X-binding mutants of NUAK1 and MARK4 and find that these are hyper-ubiquitinated and not phosphorylated at their T-loop residue targeted by LKB1 when expressed in cells, suggesting that polyubiquitination may inhibit these enzymes. The results of the present study demonstrate that NUAK1 and MARK4 are substrates of USP9X and provide the first evidence that AMPK family kinases are regulated by unusual Lys(29)/Lys(33)-linked polyubiquitin chains.
Insights
AMPK-related kinases NUAK1 and MARK4 are regulated by the deubiquitinating enzyme USP9X. This study reveals unusual Lys(29)/Lys(33)-linked polyubiquitin chains control these key cell signaling proteins.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- AMPK-related kinases, including NUAK1 and MARK4, are crucial regulators of cell polarity and proliferation.
- These kinases are activated by the LKB1 tumor suppressor kinase.
- The precise regulatory mechanisms, particularly post-translational modifications, are not fully understood.
Purpose of the Study:
- To investigate the role of ubiquitination and deubiquitination in the regulation of NUAK1 and MARK4.
- To identify the specific ubiquitin linkages involved in the regulation of these kinases.
- To explore the functional consequences of ubiquitination on NUAK1 and MARK4 activity.
Main Methods:
- In vivo polyubiquitination assays.
- Co-immunoprecipitation to study protein interactions.
- Knockdown and overexpression studies of USP9X.
- Analysis of ubiquitin chain topology (Lys(29)/Lys(33) linkages).
- Site-directed mutagenesis to identify non-binding mutants.
Main Results:
- NUAK1 and MARK4 were found to be polyubiquitinated in vivo and interact with USP9X.
- USP9X deubiquitinates NUAK1 and MARK4, with knockdown of USP9X increasing their polyubiquitination.
- Ubiquitin chains linked by Lys(29) and/or Lys(33) were identified on NUAK1 and MARK4.
- Non-USP9X-binding mutants exhibited hyper-ubiquitination and reduced LKB1-mediated phosphorylation.
- AMPK and other AMPK-related kinases also showed polyubiquitination.
Conclusions:
- NUAK1 and MARK4 are substrates of the deubiquitinating enzyme USP9X.
- The study provides the first evidence for regulation of AMPK family kinases by Lys(29)/Lys(33)-linked polyubiquitin chains.
- Polyubiquitination, mediated by these unusual linkages, may serve as an inhibitory mechanism for NUAK1 and MARK4 activity.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
PI3K/mTOR/AKT Signaling Pathway
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

